ESC 365 - How can we affect vascular function and structure pharmacologically

EAPC Premium Access

How can we affect vascular function and structure pharmacologically

Session: Maintaining vascular health to reduce CV risk

Topic: Cardiovascular Risk Assessment

Speaker: Assistant Professor A. Gevaert (Antwerp, BE)

Event: ESC Preventive Cardiology 2023

Congress Presentation

Add to my library

About the speaker

Assistant Professor Andreas Bernard Gevaert

University of Antwerp, Antwerp (Belgium)

7 presentations

0 follower

4 more presentations in this session

How do vascular function and structure predict CV risk

Speaker: Professor C. Antoniades (Oxford, GB)

How to assess vascular function and structure

Speaker: Professor J. Pitha (Prague, CZ)

How can we affect vascular function and structure by non-pharmacological approaches

Speaker: Doctor N. Kraenkel (Berlin, DE)

Discussion – Maintaining vascular health to reduce CV risk

Access the full session

Maintaining vascular health to reduce CV risk

Speakers: Assistant Professor A. Gevaert, Professor C. Antoniades, Professor J. Pitha, Doctor N. Kraenkel

About the event

ESC Preventive Cardiology 2023

13 April - 15 April 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources